-
The Importance of Neuroendocrine Tumor Imaging
Dr. Giuseppe Esposito, chief of nuclear medicine and professor of radiobiology at MedStar Georgetown, presented on the management of imaging neuroendocrine tumors at the 12th Annual Ruesch Center Symposium.
Category: News
-
Dr. Marshall on the Potential Utility of Trastuzumab Deruxtecan in HER2+ Gastric Cancer
John L. Marshall, MD, discusses the potential utility of fam-trastuzumab deruxtecan-nxki (Enhertu) in HER2-positive gastric cancer.
Category: News
-
Dr. Marshall on the Results of the DESTINY-Gastric02 Trial in Gastric/GEJ Cancer
John L. Marshall, MD, discusses the results of the phase 2 DESTINY-Gastric02 trial (NCT04014075) in HER2-positive gastric and gastroesophageal junction (GEJ) cancers.
Category: News
-
Early Onset Colorectal Cancer: Why Is This Happening?
“When I started practice nearly 30 years ago, there was no one in my clinic with colon cancer under the age of 50. But a little over 10 years ago, I started noticing more and more younger people coming in with CRC,” recalls John Marshall, MD
Category: News
-
Could Your Patient Benefit? New Trials in Colorectal Cancer
Dr. John Marshall discusses a number of late-phase studies in colorectal cancer that have opened in recent months. Could one of your patients benefit from being enrolled?
Category: News
-
The Marshalls Open a Candid Conversation About Cancer
The Marshalls go beyond the pages of their new memoir, Off Our Chests: A Candid Tour Through the World of Cancer, to discuss how Liza’s diagnosis of triple-negative breast cancer changed their lives and the key messages they hope readers will take from their book.
Category: News
-
Molecular Profiling and the Promise of Precision Medicine
ONCOLOGY® sat down with John L. Marshall, MD, to discuss how personalized approaches to treating various gastrointestinal malignancies has changed the therapy landscape.
Category: News
-
GI Cancer Expert Is Searching for Big Leaps in Care
Marshall has made it his mission to improve the lives of patients with GI cancers through innovative research, personalized medicine, and focused advocacy at Georgetown University’s Otto J Ruesch Center for the Cure of Gastrointestinal Cancer, which he helped establish in 2008.
Category: News
-
Frontline Systemic Therapy in HCC Patients
Aiwu Ruth He, MD, PhD, highlights factors that influence her use of frontline systemic therapy in patients with unresectable hepatocellular carcinoma.
Category: News
-
The Marshall Family Faces Off Against TNBC
“In reflecting on this journey, the Marshalls discussed their choice to write a book about it. It came, in part, from taking a hard look at the patient and provider perspectives of a cancer journey. The pair saw the opportunity to convey to other health care providers how to best communicate with and understand their patients.”
Category: News